CD44 and breast cancer: We first used the breast cancer as a model to analyze the correlation between IgGhigh cells and CD44+/CD24−/low BCSCs on adjoined sections by immunohistochemistry using RP215 and anti-human CD44v6, a CD44 isoform, which is more correlate to tumor invasion [31].